News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cytochroma Inc. to Present at Upcoming Investor Conferences


9/7/2011 11:19:13 AM

MARKHAM, ON, Sept. 7, 2011 /PRNewswire/ -Cytochroma today announced that the Company will be presenting a corporate overview at the following investor conferences:

  • Charles W. Bishop, Cytochroma's President and Chief Executive Officer will be presenting at the Stifel Nicolaus Healthcare Conference 2011 at 4:25 PM ET on Wednesday, September 7, 2011 at the Four Seasons Hotel in Boston.
  • Eric J. Messner, Cytochroma's Chief Operating Officer will be presenting at the RW Baird 2011 Health Care Conference at 1:45 PM ET on Thursday, September 8, 2011 at The New York Palace Hotel in New York City.

About Cytochroma

Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism associated with chronic kidney disease (CKD). The Company specializes in developing new therapies which are designed to safely and effectively treat patients with stage 3, 4 or 5 CKD. Cytochroma also has a portfolio of CYP24 and phosphate-uptake inhibitors in early stage development.

For more information about Cytochroma, please visit www.cytochroma.com.

SOURCE Cytochroma


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES